# Effect of Linagliptin on TRL Metabolism

> **NCT02280174** · PHASE4 · UNKNOWN · sponsor: **Ministry of Public Health, Argentina** · enrollment: 20 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** linagliptin

## Key facts

- **NCT ID:** NCT02280174
- **Lead sponsor:** Ministry of Public Health, Argentina
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2014-11
- **Final completion:** 2016-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2014-11-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02280174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02280174, "Effect of Linagliptin on TRL Metabolism". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02280174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*